Search Results - "van Doorn, MBA"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE) by de Visser, S.J., Uchida, N., van Vliet-Daskalopoulou, E., Fukazawa, I., van Doorn, M.B.A., van den Heuvel, M.W., Machielsen, C.S.M., Uchida, E., Cohen, A.F.

    Published in Contraception (Stoneham) (01-09-2003)
    “…To compare the pharmacokinetic parameters and safety of the progestagen, Org 30659, (17α)-17-hydroxy-11-methylene-19-norpregna-4,15-dien-20-yn-3-one), and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema by van Doorn, Martijn B.A., Burggraaf, Jacobus, van Dam, Tijtje, Eerenberg, Anke, Levi, Marcel, Hack, Cornelis E., Schoemaker, Rik C., Cohen, Adam F., Nuijens, Jan

    Published in Journal of Allergy and Clinical Immunology (01-10-2005)
    “…Hereditary angioedema (HAE) is a congenital disorder with recurrent attacks of localized swelling of submucosal tissue, subcutaneous tissue, or both caused by…”
    Get full text
    Journal Article
  5. 5